289 related articles for article (PubMed ID: 31186424)
1. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
[TBL] [Abstract][Full Text] [Related]
2. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
[TBL] [Abstract][Full Text] [Related]
3. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
7. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
[TBL] [Abstract][Full Text] [Related]
8. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
[TBL] [Abstract][Full Text] [Related]
9. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of Cpf1 in complex with CRISPR RNA.
Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
[TBL] [Abstract][Full Text] [Related]
11. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
[TBL] [Abstract][Full Text] [Related]
12. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM structure of the RNA-guided ribonuclease Cas12g.
Li Z; Zhang H; Xiao R; Han R; Chang L
Nat Chem Biol; 2021 Apr; 17(4):387-393. PubMed ID: 33495647
[TBL] [Abstract][Full Text] [Related]
14. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
[TBL] [Abstract][Full Text] [Related]
16. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.
Zhang C; Konermann S; Brideau NJ; Lotfy P; Wu X; Novick SJ; Strutzenberg T; Griffin PR; Hsu PD; Lyumkis D
Cell; 2018 Sep; 175(1):212-223.e17. PubMed ID: 30241607
[TBL] [Abstract][Full Text] [Related]
18. Structural and biochemical insights into CRISPR RNA processing by the Cas5c ribonuclease SMU1763 from Streptococcus mutans.
Lemak S; Serbanescu MA; Khusnutdinova AN; Ruszkowski M; Beloglazova N; Xu X; Brown G; Cui H; Tan K; Joachimiak A; Cvitkovitch DG; Savchenko A; Yakunin AF
J Biol Chem; 2021 Nov; 297(5):101251. PubMed ID: 34592310
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
20. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]